Sera Prognostics Birth Risk Blood Test

LabCorp today announced the nationwide availability of the PreTRM blood test, developed by Sera Prognostics, which provides an "early and individualized" prediction of preterm birth risk for pregnant women. The companies had previously announced a strategic collaboration through which LabCorp became the exclusive US distributor of Sera’s PreTRM test. LabCorp was also a lead investor in Sera’s recently closed Series C financing round.